MedTrace Logo

EpiFaith Syringe for Epidural Space Detection

NCT03983109 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-07-05

Study results available
· View outcomes & findings →

Summary

The objective of the study is to verify the efficacies of both air and saline based procedure of EpiFaith syringe for assisting the needle localization of the epidural space.

Conditions

  • Epidural Localization

Interventions

DEVICE

EpiFaith loss of resistance detect syringe

An EpiFaith syringe will be used to detect the loss of resistance and facilitate the needle localization.

Sponsors & Collaborators

  • Flat Medical Co., Ltd

    lead OTHER

Principal Investigators

  • Chien-Kun Ting, MD · Taipei Veterans General Hospital, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-23
Primary Completion
2020-06-01
Completion
2020-06-01

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03983109 on ClinicalTrials.gov